Nexus AG/€NXU
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Nexus AG
Nexus AG, founded in 1989 and headquartered in Donaueschingen, Germany, develops and distributes software solutions for the international healthcare market. Its product portfolio includes the clinical information system (NEXUS / HIS) and integrated diagnostic modules (NEXUS / DIS), addressing functional requirements of hospitals, psychiatric clinics, rehabilitation, and diagnostic centers. The company operates in seven European countries and supports customers in an additional 23 countries through certified dealers. As of December 31, 2023, Nexus AG employed approximately 1,930 individuals. In January 2025, the company was taken private following a tender offer by the investment firm TA Associates. (,,)
Ticker
€NXU
Sector
Primary listing
XETRA
Employees
1,930
Headquarters
Website
Nexus AG Metrics
BasicAdvanced
€1.2B
35.79
€1.98
0.69
€0.23
0.32%
Price and volume
Market cap
€1.2B
Beta
0.69
52-week high
€74.30
52-week low
€47.55
Average daily volume
670
Dividend rate
€0.23
Financial strength
Current ratio
2.113
Quick ratio
1.988
Long term debt to equity
4.923
Total debt to equity
6.719
Dividend payout ratio (TTM)
11.60%
Interest coverage (TTM)
19.24%
Profitability
EBITDA (TTM)
49.349
Gross margin (TTM)
29.78%
Net profit margin (TTM)
12.28%
Operating margin (TTM)
14.08%
Effective tax rate (TTM)
24.66%
Revenue per employee (TTM)
€140,000
Management effectiveness
Return on assets (TTM)
5.44%
Return on equity (TTM)
12.28%
Valuation
Price to earnings (TTM)
35.788
Price to revenue (TTM)
4.396
Price to book
4.16
Price to tangible book (TTM)
15.5
Price to free cash flow (TTM)
23.768
Free cash flow yield (TTM)
4.21%
Free cash flow per share (TTM)
2.987
Dividend yield (TTM)
0.32%
Forward dividend yield
0.32%
Growth
Revenue change (TTM)
6.57%
Earnings per share change (TTM)
34.05%
3-year revenue growth (CAGR)
11.73%
10-year revenue growth (CAGR)
11.43%
3-year earnings per share growth (CAGR)
18.62%
10-year earnings per share growth (CAGR)
13.11%
3-year dividend per share growth (CAGR)
4.77%
10-year dividend per share growth (CAGR)
5.87%
Bulls say / Bears say
The European Commission’s approval of €403 million in public funding for medical device innovation with digital and AI features is set to attract an additional €826 million in private investment, expanding the potential market for Nexus AG’s diagnostic modules.
Bain Capital, Hg, and TA Associates have shown interest in acquiring Italian software developer Namirial (valued at about €900 million), reflecting strong private equity confidence in European healthcare and software companies such as Nexus AG.
Global 'smart hospital' market forecasts point to growth reaching $148 billion by 2029, propelled by uptake of AI, IoT, and robotics—offering major expansion prospects for Nexus AG’s clinical information systems.
Private equity firms, including TA Associates, now have greater exposure to highly leveraged companies and private credit markets, making them susceptible to liquidity squeezes and heightened default risks as the economic climate toughens.
The significant upfront and ongoing costs associated with 'smart hospital' technologies could discourage hospitals from deploying Nexus AG’s solutions, since currently only a small proportion can afford this level of digital upgrade, despite potential long-term advantages.
Ongoing enforcement of the EU Digital Markets Act and Digital Services Act, as well as wider antitrust investigations, heightens regulatory uncertainty and may place new compliance requirements on Nexus AG’s international software operations.
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Nexus AG stock?
Nexus AG (NXU) has a market cap of €1.2B as of September 15, 2025.
What is the P/E ratio for Nexus AG stock?
The price to earnings (P/E) ratio for Nexus AG (NXU) stock is 35.79 as of September 15, 2025.
Does Nexus AG stock pay dividends?
Yes, the Nexus AG (NXU) stock pays dividends to shareholders. As of September 15, 2025, the dividend rate is €0.23 and the yield is 0.32%. Nexus AG has a payout ratio of 11.6% on a trailing twelve-month basis.
When is the next Nexus AG dividend payment date?
The next Nexus AG (NXU) dividend payment date is unconfirmed.
What is the beta indicator for Nexus AG?
Nexus AG (NXU) has a beta rating of 0.69. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.